Der Kaninchen Polyklonal Anti-VKORC1-Antikörper wurde für WB, IF, IHC (p) und EIA validiert. Er ist geeignet, VKORC1 in Proben von Human und Maus zu detektieren.
VKORC1
Reaktivität: Human
WB, ELISA, IHC
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
1.0 mg/mL
Buffer
PBS containing 0.02 % Sodium Azide as preservative
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target
VKORC1
(Vitamin K Epoxide Reductase Complex, Subunit 1 (VKORC1))
Andere Bezeichnung
VKORC1
Hintergrund
Vitamin K epoxide reductase complex subunit 1 (VKORC1) is the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form which is essential for blood clotting. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is VKORC1 that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance.Synonyms: 3-epoxide reductase subunit 1, MSTP134, MSTP576, UNQ308/PRO351, VKOR, Vitamin K epoxide reductase complex subunit 1, Vitamin K1 2